Journal
BIOORGANIC & MEDICINAL CHEMISTRY
Volume 12, Issue 13, Pages 3711-3721Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2004.04.013
Keywords
synthesis; anticancer activity; carbonyl quinoxalines 1,4-di-N-oxide
Ask authors/readers for more resources
As a continuation of our research in quinoxaline 1,4-di-N-oxide and with the aim of obtaining new anticancer agents, which can improve the current chemotherapeutic treatments, new series of 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives have been synthesized and evaluated for in vitro antitumor activity against a 3-cell line panel, consisting of MCF7 (breast), NCI-H460 (lung), and SF-268 (CNS). These active compounds were then evaluated in the full panel of 60 human tumor cell lines derived from nine cancer cell types. The results have shown that, in general, anticancer activity depends on the substituents in the carbonyl group, improving in the order: ethyl < isopropyl < tert-butyl < phenyl-ones. Among these, the compounds 4c, 6e, their difluorinated analogs (4g and 6g), and 5c were the most active, with mean GI(50) values of 1.02, 0.42, 0.52, 0.15, and 0.49 muM, respectively. All of them were also found to inhibit the growth of the all of the Leukemia cell lines studied (with 75% of the GI(50) values less than 0.15 muM) and therefore, were selected for further evaluation for the in vivo hollow fiber assays. (C) 2004 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available